Maxmillian Mpina

Maxmillian Mpina

researcher0.0Global Dominance: 0.00%

Maxmillian Mpina is a co-researcher at the Ifakara Health Institute who played a key role in the development and testing of the SUM-101 malaria vaccine, which has shown promising results in early trials, potentially transforming malaria prevention strategies in sub-Saharan Africa.

Power0
Reach0
Collect

Not in the pool (under ¢1).

Recent news mentions

Maxmillian Mpina is a lead co-author of the study on the new malaria vaccine SUM-101.

New Tanzanian Malaria vaccine shows strong immune response in early trials
The Citizen – major Tanzanian English newspaper, est. 2004·TanzaniaTanzania· 2025-11-09
8.0